Jyong Biotech Ltd.(MENS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
MENS Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Jyong Biotech Ltd. (MENS), a Healthcare sector company. MENS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of MENS by reported 13-F value include BlackRock, GEODE CAPITAL MANAGEMENT, HRT FINANCIAL, based on the most recent SEC filings. MENS trades on the Nasdaq exchange and files with the SEC under CIK 1954488. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MENS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Jyong Biotech Ltd. directly from SEC EDGAR.
Net Income
FY 2025
$-4.7M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-54.7% YoYOperating Income
-26.8% YoYEPS (Diluted)
-50.0% YoYTotal Assets
+226.4% YoYTotal Debt
Op. Cash Flow
+16.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Net Income | $-4.7M -54.7% | $-3.0M +31.4% | $-4.4M | — |
| Operating Income | $-2.6M -26.8% | $-2.1M +26.5% | $-2.8M | — |
| EPS (Diluted) | $-0.06 -50.0% | $-0.04 +33.3% | $-0.06 | — |
| Total Assets | $20.8M +226.4% | $6.4M | — | — |
| Total Debt | $17.5M | — | — | — |
| Operating Cash Flow | $-3.0M +16.1% | $-3.6M -39.3% | $-2.6M | — |
Get alerted when MENS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Jyong Biotech Ltd. including:
Top Institutional Holders of MENS
BlackRock, Inc.
$538.9K260,317 shGEODE CAPITAL MANAGEMENT, LLC
$142.6K68,882 shHRT FINANCIAL LP
$104.0K50,423 shXTX Topco Ltd
$60.2K29,066 shRENAISSANCE TECHNOLOGIES LLC
$47.4K22,900 shChina Universal Asset Management Co., Ltd.
$25.0K12,100 shState of Wyoming
$23.2K11,208 shMORGAN STANLEY
$12.7K6,112 shBARCLAYS PLC
$12.3K5,931 shJPMORGAN CHASE & CO
$11.8K5,379 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $538.9K | 260,317 |
| GEODE CAPITAL MANAGEMENT, LLC | $142.6K | 68,882 |
| HRT FINANCIAL LP | $104.0K | 50,423 |
| XTX Topco Ltd | $60.2K | 29,066 |
| RENAISSANCE TECHNOLOGIES LLC | $47.4K | 22,900 |
| China Universal Asset Management Co., Ltd. | $25.0K | 12,100 |
| State of Wyoming | $23.2K | 11,208 |
| MORGAN STANLEY | $12.7K | 6,112 |
| BARCLAYS PLC | $12.3K | 5,931 |
| JPMORGAN CHASE & CO | $11.8K | 5,379 |
More Healthcare Companies
View all Healthcare →Put MENS on your watchlist
Track score changes the day Jyong Biotech Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MENS a good stock to buy?
13F Pro's AI-powered analysis of Jyong Biotech Ltd. (MENS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MENS are available on the MENS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MENS is classified as a small company.
Which hedge funds own MENS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MENS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Jyong Biotech Ltd.'s investment landscape.